NASDAQ: TRAW
Traws Pharma Inc Stock Ownership - Who owns Traws Pharma?

Insider buying vs selling

Have Traws Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Werner CautreelsChief Executive Officer2025-02-1896,348$0.01
$963.48Buy

1 of 1

TRAW insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TRAW insiders and whales buy or sell their stock.

TRAW Shareholders

What type of owners hold Traws Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michael B. Hoffman97.85%6,911,786$9.75MInsider
Jane Hoffman 2013 Descendants Michael63.96%4,518,275$6.37MInsider
Nikolay Savchuk37.72%2,664,819$3.76MInsider
Gmbh Baxalta36.85%2,603,295$3.67MInsider
Iain D. Dukes25.19%1,779,287$2.51MInsider
Armistice Capital LLC23.41%1,653,902$2.33MInsider
Orbimed Advisors LLC23.32%1,647,261$2.32MInsider
Viriom Inc23.29%1,645,100$2.32MInsider
Tyndall Capital Partners L P8.73%616,389$869.11kInsider
Orbimed Advisors LLC8.57%605,531$853.80kInstitution

1 of 3

TRAW vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TRAW4.69%95.31%Net Buying
CERO0.38%99.62%Net Selling
BOLT4.27%95.73%Net Buying
SNSE0.39%99.61%Net Selling
CARM9.53%73.98%

Traws Pharma Stock Ownership FAQ

Who owns Traws Pharma?

Traws Pharma (NASDAQ: TRAW) is owned by 17.89% institutional shareholders, 363.53% Traws Pharma insiders, and 0.00% retail investors. Michael B. Hoffman is the largest individual Traws Pharma shareholder, owning 6.91M shares representing 97.85% of the company. Michael B. Hoffman's Traws Pharma shares are currently valued at $9.75M.

If you're new to stock investing, here's how to buy Traws Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.